Biocon Limited
BIOCON
Classifica tra le azioni
#3387
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Prezzo delle azioni
$3.75
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$5.13B
Variazione (1 giorno)
-2.30%
Variazione (1 anno)
-9.49%
Paese
IN
Scambia Biocon Limited (BIOCON)
Categoria
Healthcare
Rapporto P/B per Biocon Limited (BIOCON)
Rapporto P/B al October 2026 TTM: 1.63
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Biocon Limited, il rapporto P/B attuale (TTM) è 1.63. Alla fine del 2024, era pari a 1.63.
Storico del rapporto P/B per Biocon Limited da 2004 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 1.63 | -13.16% |
| 2025 | 1.88 | 15.10% |
| 2024 | 1.63 | 18.32% |
| 2023 | 1.38 | -70.93% |
| 2022 | 4.74 | -25.52% |
| 2021 | 6.36 | 33.22% |
| 2020 | 4.78 | -20.52% |
| 2019 | 6.01 | -11.80% |
| 2018 | 6.82 | 48.33% |
| 2017 | 4.59 | 96.38% |
| 2016 | 2.34 | -18.48% |
| 2015 | 2.87 | 4.31% |
| 2014 | 2.75 | 31.60% |
| 2013 | 2.09 | 1.48% |
| 2012 | 2.06 | -37.93% |
| 2011 | 3.32 | 5.47% |
| 2010 | 3.15 | 72.13% |
| 2009 | 1.83 | -34.73% |
| 2008 | 2.80 | -36.29% |
| 2007 | 4.40 | -8.26% |
| 2006 | 4.79 | -7.95% |
| 2005 | 5.21 | -28.50% |
| 2004 | 7.28 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 6.251 | 282.91% |
US
|
|
| 13.2547 | 711.93% |
US
|
|
| 4.208 | 157.76% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 278.71% |
NL
|
